Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-99.07%Return on Invested Capital
VS
Market
Sector
Industry
History
$ 0.37Close
$ 0.29 - $ 4.28 52-Week Range
Ticker Information
Ticker
VYNECompany Name
VYNE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQVYNE THERAPEUTICS INC - Return on Invested Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
VYNE - ROIC Historical data
| Date | Invested Capital | Net Income Common Stock | Return on Invested Capital |
|---|---|---|---|
| 6/30/2025 | $ 38.91M | $ -38.55M | -99.07% |
| 3/31/2025 | $ 44.2M | $ -42.2M | -95.48% |
| 12/31/2024 | $ 52.19M | $ -39.83M | -76.33% |
| 9/30/2024 | $ 63.66M | $ -34M | -53.41% |
| 6/30/2024 | $ 75.01M | $ -28.43M | -37.9% |
| 3/31/2024 | $ 83.55M | $ -29.08M | -34.8% |
| 12/31/2023 | $ 88.95M | $ -28.45M | -31.99% |
| 9/30/2023 | $ 11.51M | $ -32.21M | -279.96% |
| 6/30/2023 | $ 17.27M | $ -35.08M | -203.13% |
| 3/31/2023 | $ 26.43M | $ -33.5M | -126.75% |
Key Performance Insights, Last 5 Years
- VYNE THERAPEUTICS INC's latest trailing twelve months (TTM) ROIC stands at -299.66%.
- Over the past 5 years, VYNE THERAPEUTICS INC's average ROIC has been -127.37%.
- The median ROIC for VYNE THERAPEUTICS INC during this period was -90.81%
- VYNE THERAPEUTICS INC reached its highest ROIC over the past 5 years at -31.99%.
- The lowest ROIC recorded by VYNE THERAPEUTICS INC in the same timeframe -353.6%
VYNE THERAPEUTICS INC's ROIC vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROIC Benchmarks
Similar metrics to ROIC:
- Cash Return on Invested Capital - [Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].
- Invested Capital - [Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
Definition of Return on Invested Capital
[Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].Net Inc. Cmn. / Inv. Capital
(=) ROIC ROIC for VYNE THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -253.88M ] / Inv. Capital [ $ 84.72M ]
(=) ROIC [ -299.66% ] VYNE - Return on Invested Capital, Last 5 years
-353.6%
Minimum
Dec 31, 2020
-31.99%
Maximum
Dec 31, 2023
-127.37%
Average
-90.81%
Median
ROIC Benchmark AnalysisMarket
The chart above depicts the distribution of ROIC for companies in the Total Stock Market. The average ROIC of the companies is 0.68% with a standard deviation of 15.2%.
The following table provides additional summary stats:
ROIC in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | -46.36% |
| max | 48.66% |
| average | 0.68% |
| median | 3.38% |
| std | 15.2% |